Trial Starts In Pfizer's Norvasc Patent Dispute
The trial began Tuesday in the longstanding patent fight between Pfizer Inc. and generic drug maker Mylan Pharmaceuticals Inc. over Pfizer's blockbuster drug Norvasc....To view the full article, register now.
Already a subscriber? Click here to view full article